According to ParkinsonNewsToday.com, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) revamped the Fox Trial Finder, a tool that matches Parkinson’s patients and healthy volunteers with clinical trial studies.
“At the Foundation, our single urgent goal is to eliminate Parkinson’s disease,” Sohini Chowdhury, MJFF’s deputy CEO, said in a press release. “It will take the efforts of all of us to better connect the millions impacted by the disease worldwide to opportunities that could advance breakthroughs in treatments and ultimately a cure.”
The Fox Trial Finder team claims it will help alleviate the taxing burden of trial recruitment. Insufficient amounts of volunteers is the cause of 85% of clinical trial delays. 30% of studies never even begin, Chowdhury also said.
The clinical trial finder is powered by WCG’s CenterWatch iConnect platform for ease of use. WCG provides services and technologies aimed at improving clinical trial quality and efficiency.
iConnect also lets trial sponsors establish and manage recruitment efforts from one platform, enabling them to gauge each part of each study’s enrollment strategy. The potential result is better predictability and lower outreach costs.
“We are proud to be accelerating research and moving our mission forward to get safer, more effective treatments into the hands of patients living with Parkinson’s disease as efficiently as possible while maintaining the highest quality and ethical research standards,” said Donald A. Deieso, PhD, executive chairman and CEO of WCG. “MJFF’s decision to redesign its new Fox Trial Finder on our iConnect platform will make clinical research much more accessible and easier to navigate for patients and their families.”
WCG CenterWatch iConnect is visited monthly by more than 250,000 people seeking information about clinical studies for themselves or others. In addition, the platform falls in the top three of most study-related search results overall.
“Michael J. Fox Foundation’s Fox Trial Finder has traditionally been one of the gold standards in matching patients to clinical trials,” said Lisa LaLuna, WCG’s senior vice president for patient advocacy in a press release. “We are honored to provide Michael J. Fox Foundation with a more user-friendly version for their Parkinson’s community of patients, families and supporters around the globe.”
Find more articles about clinical trials.